Researchers at Kapoose Creek Bio partner with McMaster University to develop a new synthetic biology platform for fungi-derived medicines.
May-2024
McMaster and University of Ottawa recieved funding from CBRF to expand Canada’s biomanufacturing industry for development of technology and theraputics.
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]